(Q35591181)

9 August 2017

1 reference

title

Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients (English)

1 reference

9 August 2017

Sigmund Silber

1

1 reference

9 August 2017

1 December 2003

1 reference

Journal of Interventional Cardiology

9 August 2017

1 reference

9 August 2017

16

1 reference

9 August 2017

485-490

1 reference

9 August 2017

6

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Stent coatings and local drug delivery; state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Drug-eluting stents: cost versus clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Hippocrates revisited: the evidence for drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Drug-eluting stents: costs versus clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

New frontiers in cardiology: drug-eluting stents: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

New frontiers in cardiology: drug-eluting stents: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

[Position paper on intracoronary brachytherapy].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

A paclitaxel-eluting stent for the prevention of coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

SCAI statement on drug-eluting stents: practice and health care delivery implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Images in clinical medicine. Paclitaxel and cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8183.2003.01065.X

10.1046/J.1540-8183.2003.01065.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14632945